Histological Grading and Staging of Chronic Hepatitis.
Histological Grading and Staging of Chronic Hepatitis.
复制标题
DOI:
10.1002/cld.1014
复制
发表时间:
2021-04-01
影响因子:
--
通讯作者:
Krishna, Murli
中科院分区:
文献类型:
--
作者:
Krishna, Murli
The liver biopsy is often an important part of the evaluation of a patient with abnormal liver function. It is the only procedure that provides a direct visualization of the extent of liver injury. If the etiology of dysfunction is not clear or involves multiple possible causes, the biopsy findings may guide the clinical team toward establishing a diagnosis and appropriate clinical management. In the setting of a known chronic hepatitis (CH), a biopsy provides information regarding:(1) the extent of ongoing necroinflammatory activity, which is a precursor to fibrogenesis; and (2) the extent of fibrosis. These two variables have drawn comparisons with neoplastic processes and have thus been termed “grade” and “stage,” respectively. In addition, the biopsy may reveal other concurrent processes (such as fatty liver disease and iron overload) that may influence the prognosis and management. This review is limited to grading and staging of CH, such as viral and autoimmune hepatitis, and does not include discussion of steatohepatitis. It outlines the goals and basic elements of grading and staging, a historical perspective, and the common currently used systems. 1-3